Profile

Anthony J. Bleyer, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

97 Ratings
26 Comments
 

Anthony J. Bleyer, M.D.

Professor,

Clinical Interests

Diabetic Kidney Disease, Peritoneal Dialysis, New treatments for kidney disease, Epidemiology of kidney disease, Hemodialysis, Kidney Diseases (Inherited)

Contact Information

Returning Patient Appointments: 336-716-4513
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • B.S., Rensselaer PolyTechnical Institute, 1982
  • M.D., Baylor College of Medicine, 1987
  • Internship, Internal Medicine, Johns Hopkins Affil Hosps, 1988
  • Residency, Internal Medicine, Johns Hopkins Affil Hosps, 1990
  • Fellowship, Univ of Pa School of Medicine, 1992

Board Certifications

  • American Board of Internal Medicine, Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Int'L Society Peritoneal Dialy
  • Nat'L Kidney Foundation
  • Am Soc Of Nephrology

NPI Number

  • 1346225778
Anthony J. Bleyer, M.D.

Doctor Rating

4.7 out of 5

97 Ratings
26 Comments
 

Anthony J. Bleyer, M.D.

Professor, Nephrology

Research Interests

Kidney Failure, Chronic; Renal Dialysis; Kidney Diseases; Nephrology; Mucoproteins
More »

Contact Information

Academic: 336-716-4513 | Department: 336-716-4650

Recent Publications

Tamm Horsfall glycoprotein and uromodulin: it is all about the tubules! [editorial]. Bleyer AJ, Kmoch S.. Clin J Am Soc Nephrol. 2016;11(1):6-8.

Development and validation of a mass spectrometry-based assay for the molecular diagnosis of mucin-1 kidney disease. Blumenstiel B, DeFelice M, Birsoy O, Bleyer AJ, Kmoch S, Carter TA, Gnirke A, Kidd K, Rehm HL, Ronco L, Lander ES, Gabriel S, Lennon NJ.. J Mol Diagn. 2016;18(4):566-571.

Acadian variant of Fanconi Syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6. Hartmannova H, Piherova L, Tauchmannova K, Kidd K, Acott PD, Crocker JF, Oussedik Y, Mallet M, Hodanova K, Stranecky V, Pristoupilova A, Baresova V, Jedlickova I, Zivna M, Sovova J, Hulkova H, Robins V, Vrbacky M, Pecina P, Kaplanova V, Houstek J,.. Hum Mol Genet. 2016;():.

Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia. Bolar NA, Golzio C, Zivna M, Hayot G, Van Hemelrijk C, Schepers D, Vandeweyer G, Hoischen A, Huyghe JR, Raes A, Matthys E, Sys E, Azou M, Gubler MC, Praet M, Van Camp G, McFadden K, Pediaditakis I, Pristoupilova A, Hodanova K, Vylet'al, P,.. Am J Hum Genet. 2016;99(1):174-187.

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report. Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O.. Kidney Int. 2015;88(4):676-683.

Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis. Bleyer AJ, Wright D, Alcorn H.. Clin Nephrol. 2015;83(5):286-292.

Climate temperature affects the age of onset of end stage renal disease [abstract]. Bleyer ME, Abbas MM, Swain E, Kidd KO, Bleyer AJ.. J Am Soc Nephrol. 2015;26(Abstract Suppl):208A.

Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A,.. Clin J Am Soc Nephrol. 2014;9(3):527-535.

Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Murea M, James KM, Russell GB, Byrum GV III, Yates JE, Tuttle NS, Bleyer AJ, Burkart JM, Freedman BI.. Clin J Am Soc Nephrol. 2014;9(4):764-770.

Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ.. JAMA Intern Med. 2014;174(9):1442-1449.

Autosomal dominant tubulointerstitial kidney disease: of names and genes [editorial commentary]. Bleyer AJ, Kmoch S.. Kidney Int. 2014;86(3):459-461.

A population-based study of the U.S. population shows the majority of persons cannot donate due to preventable diseases and socio-economic conditions [abstract]. Bleyer AJ, Reeves-Daniel AM.. J Am Soc Nephrol. 2014;25(Abstract Suppl):67A.

Comparison of age of onset of end-stage kidney disease in medullary cystic kidney disease types 1 and 2 [abstract]. Abbas MM, Kidd KO, Kmoch S, Bleyer AJ.. J Am Soc Nephrol. 2014;25(Abstract Suppl):771A.

Broadening the differential of cystic kidney disease: disease [abstract]. Corapi KM, McGrath MM, Bleyer AJ, Greka A.. J Am Soc Nephrol. 2014;25(Abstract Suppl):423A.

Uromodulin (UMOD) gene polymorphism shows different associations with chronic kidney disease in Euro-American versus African-American individuals with diabetes mellitus [abstract]. Bleyer AJ, Kmoch S, Langefeld CD, Raffield LM, Lu L, Bowden DW, Freedman BI.. J Am Soc Nephrol. 2014;25(Abstract Suppl):418A.

Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, Hulkova H, Sovova J, Vylet'al P, Antignac C, Guttman M, Handsaker RE,.. Nat Genet. 2013;45(3):299-303.

Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study. Gunzler D, Bleyer AJ, Thomas RL, O Brien A, Russell GB, Sattar A, Iyengar SK, Thomas C, Sedor JR, Schelling JR.. BMC Nephrol. 2013;14():124.

Clinical implications of the relationship between low calcium concentration dialysate and sudden death [editorial]. Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(5):706-707.

American Society of Nephrology quiz and questionnaire 2012: electrolytes. Palmer BF, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(6):1048-1053.

American Society of Nephrology quiz and questionnaire 2012: transplantation. Brennan DC, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(7):1267-1272.

American society of nephrology quiz and questionnaire 2012: glomerulonephritis. Fervenza FC, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(8):1460-1465.

American society of nephrology quiz and questionnaire 2012: renal replacement therapy. Mehrotra R, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(9):1632-1636.

Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K.. Ann Intern Med. 2013;159(4):233-242.

Kidney transplant exposing central diabetes insipidus [abstract]. Robinson TW, Bleyer AJ.. J Am Soc Nephrol. 2013;24(Abstract Suppl):288A.

Variable clinical presentation in individuals with a MUC1 mutation causing medullary cystic kidney disease type 1 [abstract]. Bleyer AJ, Kmoch S, Kidd KO, Robins VC, Hodanova K.. J Am Soc Nephrol. 2013;24(Abstract Suppl):304A.

Risk of catheter-related bloodstream infections in elderly patients on hemodialysis [abstract]. Murea M, James KM, Russell GB, Bleyer AJ, Burkart JM, Freedman BI.. J Am Soc Nephrol. 2013;24(Abstract Suppl):396A.

Pegloticase, a recombinant uricase for the treatment of advanced gout, maintains therapeutic concentrations during dialysis [abstract]. Bleyer AJ, Wright DE, Glicklich A.. J Am Soc Nephrol. 2013;24(Abstract Suppl):461A.

Renin gene mutation causing anemia and kidney injury in childhood [abstract]. Hashim FQ, Bleyer AJ, Kmoch S, Neiberger RE.. J Am Soc Nephrol. 2013;24(Abstract Suppl):608A.

Implications of an unusual diagnosis: uromodulin-associated kidney disease [abstract]. Bolanos JA, Bleyer AJ, Yuan CM, Thurlow JS.. J Am Soc Nephrol. 2013;24(Abstract Suppl):608A.

The use of a U.S. veterans' chronic kidney disease database to model the SPRINT (Systolic Blood Pressure Intervention) Trial [abstract]. Bleyer AJ, Lu JL, Molnar MZ, Ma JZ, Canada RB, Kalantar-Zadeh K, Kovesdy CP.. J Am Soc Nephrol. 2013;24(Abstract Suppl):680A-681A.

Mutations in a large VNTR of MUC1 are frequent in autosomal dominant medullary cystic kidney disease (MCKD) [abstract]. Moriniere V, Hollebecque S, Lebbah S, Megarbane A, Gnirke A, Blumenstiel B, Bleyer AJ, Kirby A, Knebelmann B, Antignac C.. J Am Soc Nephrol. 2013;24(Abstract Suppl):68A.

Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis [abstract]. Bleyer AJ, Wright DE, Glicklich A.. Arthritis Rheum. 2013;65(Suppl 10):S497-S498.

Medullary cystic kidney disease type 1. Bleyer AJ, Kmoch S. In: Pagon RA, Adam MP Ardinger HH, et al, eds. GeneReviews [internet]. Seattle (WA);2013: .

Nephrology quiz and questionnaire: electrolytes. Palmer BF, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2012;7(6):1047-1052.

Cardiovascular disease: modifiable risk factors for sudden death in dialysis patients. Bleyer AJ, Hawfield A.. Nat Rev Nephrol. 2012;8(6):323-324.

Nephrology quiz and questionnaire: transplantation. Hricik DE, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2012;7(7):1190-1194.

Nephrology quiz and questionnaire: renal replacement therapy. Golper TA, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2012;7(8):1347-1352.

Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Murea M, Moran T, Russell GB, Shihabi ZK, Byers JR, Andries L, Bleyer AJ, Freedman BI.. Am J Nephrol. 2012;36(5):488-496.

Gout: a step forward [editorial]. Bleyer AJ, Kmoch S.. Adv Chronic Kidney Dis. 2012;19(6):356-357.

Changes in serum urate and urate excretion with age. Stiburkova B, Bleyer AJ.. Adv Chronic Kidney Dis. 2012;19(6):372-376.

Glycated albumin (GA), not hemoglobin A1c (HbA1c), predicts cardiovascular hospitalizations and length of stay (LOS) in dialysis patients with diabetes [abstract]. Murea M, Russell GB, Bleyer AJ, Freedman BI.. J Am Soc Nephrol. 2012;23():751A.

Uromodulin-associated kidney disease. Bleyer AJ, Zivna M, Kmoch S.. Nephron Clin Pract. 2011;118(1):c31-c36.

The APOL1 gene and allograft survival after kidney transplantation. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI.. Am J Transplant. 2011;11(5):1025-1030.

UMOD-associated kidney disease. Bleyer AJ, Hart PS. In: Pagon RA, Bird TD, Dolan CR, eds. GeneReviews [internet]. Seattle (WA): University of Washington;2011: NBK1356.

Familial juvenile hyperuricemic nephropathy type 2. Kmoch S, Zivna M, Bleyer AJ. In: Pagon RA, Bird TD, Dolan CR, eds. GeneReviews [internet]. Seattle (WA): University of Washington;2011: NBK53700.

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Graham AD, Mauck VL, Russell GB, Bleyer AJ, et al.. Clin J Am Soc Nephrol. 2011;6(7):1635-1643.

The 2010 nephrology quiz and questionnaire: part 1. Glassock RJ, Bleyer AJ, Hricik DE, Palmer BF.. Clin J Am Soc Nephrol. 2011;6(9):2318-2327.

The 2010 nephrology quiz and questionnaire: part 2. Glassock RJ, Bleyer AJ, Bargman JM, Fervenza FC.. Clin J Am Soc Nephrol. 2011;6(10):2534-2547.

Sickle cell trait is not associated with ESRD susceptibility in African Americans [abstract]. Freedman BI, Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW.. J Am Soc Nephrol. 2011;22(Abstract Suppl):463A.

Women are extremely disproportionately affected by high panel reactive antibody levels prior to kidney transplantation [abstract]. Bleyer AJ, Adams PL, Russell GB.. J Am Soc Nephrol. 2011;22(Abstract Suppl):956A.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Diabetic Kidney Disease, Peritoneal Dialysis, New treatments for kidney disease, Epidemiology of kidney disease, Hemodialysis, Kidney Diseases (Inherited)
Anthony J. Bleyer, M.D.

Anthony J. Bleyer, M.D.

Professor, Nephrology

Doctor Rating

4.7 out of 5

Anthony J. Bleyer, M.D.97 Ratings
26 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

8/31/2016

He explains extremely well. He's the best in regard to care and concern.

8/26/2016

Dr Bleyer is an excellent doctor and I am very fortunate to have him as my doctor. He cares about his patients and keeps a close watch on my kidney transplant.

8/25/2016

Good.

8/23/2016

Dr. Blyer is excellent. He takes all the time necessary to discuss my condition and we work at an acceptable plan on a mutual basis to deal with my health. I really appreciate that Dr. Blyer is not hurried and demonstrates flexibility when listening to and accommodating my needs.

8/5/2016

*Dr. Bleyer is an excellent doctor who has genuine concern for his patients well being.

8/2/2016

*Dr. Bleyer is without question the BEST doctor I've ever had in my 74 yrs. Never had a doctor who took such a personal & professional interest in my health care.

8/1/2016

Very good.

7/27/2016

Excellent care provider who has shown great concern for my care since _____ once.

7/3/2016

I feel very fortunate to have Dr. Bleyer as my care provider.

6/8/2016

I feel very fortunate to have *Dr. Bleyer as my nephrologist. Through his persistent effort he discovered that I had renal care carcinoma and it was caught early & removed. I feel very lucky.

5/31/2016

Dr Bleyer is an outstanding physician. He has been with me since before my kidney transplant in 1995 and is one of the primary reasons I'm alive today.

5/25/2016

Have been seeing *Dr. Bleyer since he diagnosed by WG in 2000 great person & MD.

5/23/2016

I feel very lucky to have Dr. Bleyer as my nephrologist. He is always on top of my kidney health and well being. If I have an issue he gets to the bottom of the problem. He also, always gets back to me on my questions. I do not feel like a number with Dr. Bleyer. He is very caring and personable. Dr. Bleyer is a great doctor.

5/3/2016

We feel that Dr Bleyer is an excellent care provider, and would not consider going anywhere else!

4/19/2016

*Dr. Byer is a very caring dr. I have never had a dr. like him who concerned about your health. Thank you for letting be a doctor @ your hospital.

4/19/2016

It is good.

4/14/2016

*Dr. Bleyer is the best. I have put my life in his hands and he has kept me going.

3/22/2016

Thank God for *Dr. Bleyer.

3/1/2016

Good.

2/23/2016

Dr. Bleyer Is a excellent doctor and he has got me in as good of health as can be. I see him every 3 months so that I do not have any problems and he always send me any blood work by MY WAKE HEALTH and I really appreciate having this. I wish all Doctors were as nice and as concerned about there patients as Dr. Bleyer is.

2/22/2016

If i do not have an interpreter, then I will not understand what Dr. Bleyer said something. So it is good thing that I have an interpreter so I mostly understand what Dr. Bleyer tried to explain to me about my kidney situation. He cares about my kidney function. I am glad that he is my doctor and seeing him every 6 months for many years.

1/28/2016

Great doctor both me & my daughter go to him.

1/8/2016

Thank you for taking the time to answer questions and speak to my father.

1/7/2016

Good.

1/7/2016

*Dr. Bleyer is a caring Christian man - that's why I trust him and his opinions.

1/1/2016

I have always had exceptional care from Dr. Anthony Bleyer.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.